|
Remark |
G Protein-coupled receptors
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
Ion channels
|
Cys-loop superfamily
|
Glutamate-gated cation channels
|
Epithelial and related channels
|
Ryanodine and IP3 receptors
|
Voltage-gated cation channels
|
Na+ channel, SCN alpha, NaV1.x
|
sodium channel
|
Ca2+ channel, CACN alpha-1, CaVx.x
|
calcium channel N type [HSA:774] [KO:K04849]
|
calcium channel L type [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
|
calcium channel T type [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
|
Mibefradil [DG:DG00328]
|
D08217 Mibefradil (INN)
D05024 Mibefradil dihydrochloride (USAN)
|
Blocker
Blocker
|
Valproic acid [DG:DG00849]
|
Flunarizine [DG:DG01006]
|
Efonidipine [DG:DG01382]
|
Otilonium [DG:DG02143]
|
Zonisamide [DG:DG02380]
|
Aranidipine
|
Ethosuximide
|
Penfluridol
|
voltage-gated Ca2+ channel T type alpha-1I [HSA:8911] [KO:K04856]
|
voltage-dependent calcium channel alpha-2/delta-1 [HSA:781] [KO:K04858]
|
voltage-dependent calcium channel alpha-2/delta-2 [HSA:9254] [KO:K04859]
|
voltage-dependent calcium channel alpha-2 [HSA:781 9254 55799 93589] [KO:K04858 K04859 K04860 K04861]
|
calcium channel
|
K+ channel, KCNA, Kv1.x (Shaker)
|
K+ channel, KCNC, Kv3.x (Shaw)
|
K+ channel, KCND, Kv4.x (Shal)
|
K+ channel, KCNQ, Kv7.x (KQT-like)
|
K+ channel, KCNH, Kv10-12.x (Ether-a-go-go)
|
K+ channel, KCNK, K2px.x
|
K+ channel, KCNM, KCa1.x
|
potassium channel
|
Related to voltage-gated cation channels
|
Chloride channels
|
|
|
Transporters
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Monoclonal antibodies
|
|
|
Others
|